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Abstract 
Amyloid fibril formation is associated with diseases such as Alzheimer’s, Parkinson’s, and prion diseases. 
Inhibition of amyloid fibril formation by molecular chaperone proteins, such as the small heat-shock 
protein αB-crystallin, may play a protective role in preventing the toxicity associated with this form of 
protein misfolding. Reduced and carboxymethylated κ-casein (RCMκ-CN), a protein derived from milk, 
readily and reproducibly forms fibrils at physiological temperature and pH. We investigated the toxicity of 
fibril formation by RCMκ-CN using neuronal model PC12 cells and determined whether the inhibition of 
fibril formation altered its cell toxicity. To resolve ambiguities in the literature, we also investigated 
whether fibril formation by amyloid-β1–40 (Aβ1–40), the peptide associated with Alzheimer’s disease, 
was inhibited by αB-crystallin and if this affected the toxicity of Aβ. To this end, either RCMκ-CN or 
Aβ1–40 was incubated at neutral pH to induce fibril formation before treating PC12 cells and assessing 
cell viability. Incubated (fibrillar) RCMκ-CN was more toxic to PC12 cells than native RCMκ-CN with the 
highest level of toxicity being associated with mature fibrils and protofibrils. Furthermore, the toxicity of 
RCMκ-CN was attenuated when its fibril formation was inhibited, either through the chaperone action of 
αB-crystallin or when it interacted with its natural binding partners in milk, αS- and β-casein. Likewise, 
incubating Aβ1–40 with αB-crystallin inhibited both Aβ1–40 fibril formation and the associated cell 
toxicity. Importantly, by inhibiting fibril formation, αB-crystallin prevents the cell toxicity associated with 
protein misfolding. 
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Abstract Amyloid fibril formation is associated with
diseases such as Alzheimer’s, Parkinson’s, and prion
diseases. Inhibition of amyloid fibril formation by molec-
ular chaperone proteins, such as the small heat-shock
protein αB-crystallin, may play a protective role in
preventing the toxicity associated with this form of protein
misfolding. Reduced and carboxymethylated κ-casein
(RCMκ-CN), a protein derived from milk, readily and
reproducibly forms fibrils at physiological temperature and
pH. We investigated the toxicity of fibril formation by
RCMκ-CN using neuronal model PC12 cells and deter-
mined whether the inhibition of fibril formation altered its
cell toxicity. To resolve ambiguities in the literature, we
also investigated whether fibril formation by amyloid-β1–
40 (Aβ1–40), the peptide associated with Alzheimer’s
disease, was inhibited by αB-crystallin and if this affected
the toxicity of Aβ. To this end, either RCMκ-CN or
Aβ1–40 was incubated at neutral pH to induce fibril
formation before treating PC12 cells and assessing cell
viability. Incubated (fibrillar) RCMκ-CN was more toxic to
PC12 cells than native RCMκ-CN with the highest level of
toxicity being associated with mature fibrils and proto-
fibrils. Furthermore, the toxicity of RCMκ-CN was
attenuated when its fibril formation was inhibited, either
through the chaperone action of αB-crystallin or when it
interacted with its natural binding partners in milk, αS- and
β-casein. Likewise, incubating Aβ1–40 with αB-crystallin
inhibited both Aβ1–40 fibril formation and the associated
cell toxicity. Importantly, by inhibiting fibril formation,
αB-crystallin prevents the cell toxicity associated with
protein misfolding.
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RCMκ-CN Reduced and carboxymethylated κ-casein
sHsp small heat-shock protein
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide
TEM transmission electron microscopy
ThT Thioflavin T
Introduction
The formation of amyloid fibrils is associated with a
diverse array of diseases such as Alzheimer’s disease
(AD), Parkinson’s disease (PD), prion diseases, and type
II diabetes (Caughey and Lansbury 2003; Stefani and
Dobson 2003; Chiti and Dobson 2006; Roychaudhuri et
al. 2009; Yankner and Lu 2009). Amyloid fibrils are self-
assembled, ordered aggregates of a normally soluble
protein or peptide. The process of amyloid formation arises
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from initial misfolding of a globular protein or the adoption
of partial structure by an intrinsically disordered protein or
peptide. The resultant partially folded intermediate(s) expose
greater hydrophobicity to solution, which can lead to their
mutual association, via a nucleation-dependent β-sheet
stacking mechanism (Harper and Lansbury 1997; Dobson
2004; Hamley 2007), and the subsequent formation of
protofibrils and mature fibrils. Protofibrils are small, soluble
oligomeric forms of the protein that are rich in β-sheet and
resistant to degradation. Further aggregation of protofibrils
results in the formation of mature fibrils, which typically
consist of four to six strands in a helical, rope-like structure
with its β-sheet backbone orthogonal to the fibril axis.
In cell models of AD, PD, and prion diseases, the
amyloidogenic proteins associated with these diseases are
toxic in their oligomeric and/or fibrillar form but not in
their monomeric state (El-Agnaf et al. 1998; Bodles et al.
2000; Novitskaya et al. 2006; Chimon et al. 2007).
Furthermore, fibrillar aggregates of non-disease-related
proteins are toxic, which suggests that toxicity is related
to the mechanism of fibril formation and/or the overall fibril
structure (Bucciantini et al. 2002) rather than the native
state of the proteins that form them. Interestingly, evidence
suggests that soluble, prefibrillar oligomeric species are at
least, if not more, toxic than the mature fibrils, particularly
with regard to amyloid-β (Aβ) peptides, the putative
causative agents in AD (Hartley et al. 1999; Caughey and
Lansbury 2003; Hoshi et al. 2003; Chimon et al. 2007;
Haass and Selkoe 2007). Similar results have also been
reported for the putative causative agents of PD and
Creutzfeldt–Jakob disease, α-synuclein and the prion
protein, respectively, in cell culture models (Du et al.
2003; Simoneau et al. 2007). Therefore, it has been
speculated that prefibrillar oligomers, rather than mature
fibrils, are responsible for disease progression (Caughey
and Lansbury 2003; Haass and Selkoe 2007). By contrast,
others have found that mature fibrils of the prion protein are
more toxic than protofibrillar aggregates (Novitskaya et al.
2006). Thus, the most toxic species may vary depending on
the fibril-forming protein.
Previous research in our laboratory has shown that the
reduced and carboxymethylated form of the milk protein, κ-
casein (RCMκ-CN), spontaneously forms fibrils in a highly
reproducible manner over a 10–15 h timeframe when
incubated under conditions of physiological temperature
and pH, without the need for denaturants (Thorn et al.
2005). These properties of RCMκ-CN, coupled with its
ready availability, make it a very useful model to study the
process of fibril formation (Ecroyd et al. 2008) and to
screen for fibril-inhibiting compounds in a high throughput
manner (Carver et al. 2010).
In milk, κ-casein is present in a micelle-like structure
along with the other casein proteins, αS-casein (which is
comprised of the unrelated αS1- and αS2-casein proteins)
and β-casein. The primary function of these micelles is
believed to be their nutritional benefit through their role in
transporting calcium (Fox and McSweeney 1998). We have
recently shown that the interaction and aggregation of the
casein proteins also prevents fibril formation by the
amyloidogenic κ- and αS2-caseins (e.g., with β- and αS1-
casein, respectively; Thorn et al. 2005, 2008). RCMκ-CN
fibril formation is potently inhibited by αS- and β-casein in
vitro (Thorn et al. 2005). αS- and β-casein have structural
and functional properties similar to the small heat-shock
family of molecular chaperone proteins (sHsps) by inhibit-
ing the ordered and disordered forms of protein aggregation
in a chaperone-like manner (Morgan et al. 2005; Thorn et
al. 2005, 2008, 2009). In vivo, this is physiologically
relevant since amyloid-like deposits have been found in
bovine mammary tissue within calcified stones in corpora
amylacea, a disease which blocks the small milk ducts and
reduces milk secretion and flow (Reid 1972; Beems et al.
1978; Nickerson et al. 1985; Taniyama et al. 2000). We
have proposed that the amyloid deposits in corpora
amylacea are caused by κ- and αS2-casein fibril formation
due to a reduced chaperone action of the other casein
proteins (Thorn et al. 2005, 2008).
The sHsp family of molecular chaperones functions
intracellularly by interacting with and stabilizing partially
folded protein intermediates to prevent their aggregation,
particularly under stress conditions (e.g., elevated tempera-
ture; Carver et al. 2003; Ecroyd and Carver 2009). In doing
so, sHsps may play a protective role in preventing the
misfolding and subsequent fibril formation of amyloidogenic
proteins. The ubiquitously expressed αB-crystallin is the
most widely studied sHsp and has been shown to inhibit
fibril formation by a range of amyloidogenic proteins and
peptides in vitro, including Aβ, α-synuclein, RCMκ-CN,
apolipoprotein C-II, and ataxin-3 (Hatters et al. 2001; Rekas
et al. 2004, 2007; Raman et al. 2005; Wilhelmus et al.
2006a, b; Ecroyd et al. 2007; Robertson et al. 2010). The
interaction of αB-crystallin with Aβ has received the most
attention but has produced contrasting results. Stege et al.
(1999) and Liang (2000) found that αB-crystallin enhanced
β-sheet structure in Aβ. Furthermore, Stege et al. (1999)
observed that αB-crystallin inhibited the formation of mature
Aβ fibrils and so concluded that αB-crystallin stabilizes Aβ
into a more toxic β-sheet-rich oligomeric form. In support of
this, αB-crystallin enhanced the toxicity of Aβ in cultured
rat neurons (Stege et al. 1999). In contrast, Raman et al.
(2005) and Wilhelmus et al. (2006a, b) reported that αB-
crystallin inhibited fibril formation by Aβ. Wilhelmus et al.
(2006a, b) also found that αB-crystallin inhibited the toxicity
of Aβ in human brain pericytes. Likewise, the related sHsp,
αA-crystallin, inhibited fibril formation by Aβ and the
associated cell toxicity (Santhoshkumar and Sharma 2004).
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Given the proposed common mechanism of toxicity of
fibril-forming proteins (Bucciantini et al. 2002), we
investigated whether RCMκ-CN is also a suitable model
to study the toxicity of fibril formation. Furthermore, in
light of the discrepancy in the literature, we sought to
determine whether αB-crystallin is a generic inhibitor of
amyloid fibril formation and the cell toxicity associated
with this process. Similar to other fibril-forming proteins,
RCMκ-CN was more toxic to PC12 cells in its fibrillar and
prefibrillar forms compared with the native form of the
protein. In addition, pre-incubating αB-crystallin with Aβ
and RCMκ-CN inhibited both fibril formation and cell
toxicity. Finally, RCMκ-CN’s natural binding partners in
milk micelles, αS- and β-casein, also inhibited its amyloid
fibril formation and cell toxicity. Our results highlight the
importance of αB-crystallin and αS- and β-casein in
preventing fibril formation associated with AD and corpora
amylacea, respectively. Moreover, by preventing fibril
formation of different fibril-forming proteins, molecular
chaperones inhibit the general mechanism of toxicity
associated with this process.
Materials and methods
Materials
Bovine αS-, β-, and κ-casein were purchased from Sigma
Chemical Co. (St Louis, MO, USA). Prior to use, the κ-
casein was reduced and carboxymethylated as described
previously (Farrell et al. 2003). αB-Crystallin was
expressed and purified as described previously (Horwitz et
al. 1998; Aquilina et al. 2004). The concentration of each
protein was determined by spectrophotometric methods
using a Cary 5000 UV-visible spectrophotometer (Varian
Inc, Palo Alto, CA, USA), and molar absorption coeffi-
cients were calculated based on amino acid sequences.
Aβ1–40 was purchased from Peptide Institute Inc. (Osaka,
Japan). Uranyl acetate was purchased from Agar Scientific
(Stansted, UK). RPMI 1640 powder, fetal bovine serum,
horse serum, and L-glutamine were purchased from
Thermo Electron Corporation (Victoria, Australia). Penicil-
lin/streptomycin solution and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) were purchased
from Sigma Chemical Co.
PC12 cell culture
PC12 cells were grown in RPMI 1640 medium supple-
mented with 10% horse serum, 5% fetal bovine serum,
10 U/ml penicillin, and 10 μg/ml streptomycin. Cells were
cultured in uncoated 75 cm2 plastic flasks in an incubator
with 95% air and 5% CO2 at 37°C. The medium was
refreshed every 2–3 days. The day prior to treatment, the
cells were plated in to 96-well plates at a density of 2×104
cells per well in full-serum media.
Cellular toxicity of RCMκ-casein
RCMκ-CN (500 μM) was dissolved in phosphate buffer
(50 mM, pH 7.4). To determine the concentration-response
of RCMκ-CN-induced cell toxicity, RCMκ-CN was incu-
bated at 37°C for 20 h to induce fibril formation. Prior to
incubation, samples of native RCMκ-CN (non-fibrillated)
were taken and stored at −20°C. We found no difference in
the toxicity of native or incubated samples that were frozen
compared to those that were not frozen (data not shown).
Following the 20-h incubation, both the native and fibrillar
RCMκ-CN were diluted further in phosphate buffer and
added to the cells at the indicated concentrations. The
RCMκ-CN-treated cells were then incubated for 48 h
followed by an MTT assay (details below) to assess cell
viability.
To determine whether the toxicity of species formed
during RCMκ-CN fibril formation is time-dependent, the
protein (125 μM) was incubated under the same conditions
as described above, and samples of RCMκ-CN were taken
after 0, 0.5, 1, 2, 5, and 20 h of incubation and stored at
−20°C. Later, these aliquots of RCMκ-CN from the various
time points were thawed and added to the cells so that the
final concentration of protein was 0.5 μM. The cells were
incubated for 48 h followed by an MTT assay.
In some experiments, after the 20-h incubation, samples
of RCMκ-CN were ultracentrifuged at 90,000 rpm
(316,613 rcf) for 1 h to separate fibrillar (pellet) and non-
fibrillar (supernatant) species of RCMκ-CN. Following
centrifugation, the supernatant containing the non-fibrillar
RCMκ-CN was collected and the fibrillar RCMκ-CN pellet
resuspended in an equal volume of phosphate buffer. The
cells were treated with equal volumes of the pellet and
supernatant samples.
To test the effect of molecular chaperones on RCMκ-
CN-induced cell toxicity, RCMκ-CN (50 μM) was incu-
bated for 20 h in the presence of inhibitors of RCMκ-CN
fibril formation, i.e., αB-crystallin, αS-casein, and β-
casein. αB-Crystallin was incubated at 0.1:1.0, 0.5:1.0,
1.0:1.0, and 2.0:1.0 mol/mol ratio of RCMκ-CN, and αS- and
β-casein was incubated at 0.4:1.0, 0.8:1.0 and 1.6:1.0 mol/
mol ratio of RCMκ-CN. Following incubation, the samples
were added to the cells so that the final concentration of
RCMκ-CN was 0.5 μM.
Cellular toxicity of Aβ
Aβ1–40 (3.8 mM) was dissolved in ammonium hydroxide
(1%) and then diluted to 500 μM in water and stored at
αB-Crystallin inhibits amyloid fibril cell toxicity 1015
−80°C. Further dilutions were made in 50 mM phosphate
and 100 mM NaCl buffer (pH 7.4). To test the effect of αB-
crystallin on Aβ1–40-induced cell toxicity, Aβ1–40 (10 μM)
was incubated at 37°C for 72 h in the presence of αB-
crystallin at 0.01:1.0, 0.1:1.0, and 1.0:1.0 mol/mol ratio of
Aβ1–40. Samples of Aβ1–40 were taken after 0, 24, 48, and
72 h incubation and stored at −20°C. Following incubation,
the samples were added to the cells so that the final
concentration of Aβ1–40 was 0.5 μM. The cells were
incubated for 48 h and cell viability was assessed via an
MTT assay.
MTT assay
The MTT assay measures a cell’s ability to reduce yellow
MTT to purple formazan. This reaction is catalyzed by the
mitochondrial enzyme, succinate dehydrogenase. There-
fore, the MTT assay is a measure of mitochondrial activity
and thus, cell viability. After incubation of the treated cells
for 48 h, the media was removed, and 100 μl of serum-free
media containing MTT (0.25 mg/ml) was added to each
well. The cells were then incubated for an additional 2 h at
37°C, the media removed and 100 μl of DMSO added to
each well. Absorbance was measured at 570 nm on a
BMG Polarstar microplate reader (BMG Labtechnologies,
Offenburg, Germany).
Hoechst staining
PC12 cells were plated on to poly-L-lysine (10 μg/ml)
coated coverslips in 6-well culture dishes at a density of 2×
105 cells per well in full-serum medium and incubated at
37°C for 24 h. The cells were then treated with native and
fibrillar RCMκ-CN (0.5 μM) for 48 h. After the incubation
period, the media was removed by aspiration, and the cells
were washed several times in cold PBS (pH 7.4). The cells
were fixed with 3.7% formaldehyde, permeabilized in 0.1%
triton-X 100 and stained with Hoechst 33258 (2 μg/ml) for
20 min in the dark at room temperature. The coverslips
were mounted on glass slides using 90% glycerol. Cells
were viewed and recorded using a fluorescence microscope
(BX50, Olympus) with a 100× objective. Images were
recorded using a SPOT camera and a computer with SPOT
image analysis software (Diagnostic Instruments, Inc.
NSW, Australia) and analyzed using NIH imaging software
(National Institutes of Health, USA).
Thioflavin T assay
In situ thioflavin T (ThT) assays were used to monitor the
time course of fibril formation by RCMκ-CN and Aβ1–40
and to monitor the effect of molecular chaperones on fibril
formation. The proteins were incubated at 37°C for 20 h in
phosphate buffer (50 mM, pH 7.4) with 10 μM ThT in
black μClear 96-microwell plates. Fluorescence was mea-
sured with a 440 nm/490 nm excitation/emission filter set
on a Fluostar Optima plate reader (BMG Labtechnologies,
Offenburg, Germany). ThT fluorescence readings are
affected by temperature and an initial decrease in ThT
fluorescence is observed as the solutions are heated from
room temperature to 37°C (Thorn et al. 2005; Ecroyd et al.
2008). Therefore, the change in ThT fluorescence was
measured after this initial decrease.
Transmission electron microscopy
Samples from the above experiments were prepared for
transmission electron microscopy (TEM) by adding 2 μl of
protein solution to Formvar and carbon-coated nickel grids
(SPI Supplies, West Chester, PA). The grids were then
washed three times with 10 μl of water and negatively
stained with 10 μl of uranyl acetate (2% w/v). Samples
were viewed using a Philips CM100 transmission electron
microscope (Philips, Eindhoven, The Netherlands).
Statistics
One-way analysis of variance was performed with Bonfer-
roni’s and Dunnett’s post hoc tests depending on experi-
mental design.
Results
The fibrillar state of RCMκ-CN is cytotoxic to PC12 cells
Previous research has shown that amyloid fibril-forming
proteins are more toxic in an aggregated, fibrillar state
compared to their native, non-fibrillar form (El-Agnaf et al.
1998; Bodles et al. 2000; Bucciantini et al. 2002;
Novitskaya et al. 2006; Chimon et al. 2007). To determine
whether this was also the case for RCMκ-CN, PC12 cells
were treated with RCMκ-CN in its native state and
following incubation in phosphate buffer (50 mM,
pH 7.4) at 37°C for 20 h (Thorn et al. 2005; Ecroyd et al.
2007, 2008), conditions under which it forms fibrils (i.e.,
fibrillar RCMκ-CN). Both native and fibrillar RCMκ-CN
caused a concentration-dependent decrease in PC12 cell
survival (Fig. 1). However, fibrillar RCMκ-CN was much
more toxic at lower concentrations compared with native
RCMκ-CN. At 0.5 μM, fibrillar RCMκ-CN reduced cell
viability to 66±3% compared with 90±4% for native
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RCMκ-CN. Pre-formed RCMκ-CN fibrils, in the presence
of cell media, remain in a fibrillar state for at least 48 h as
indicated by ThT fluorescence and TEM images showing
the extensive presence of mature fibrils (data not shown).
Furthermore, fibril formation by RCMκ-CN still occurs,
albeit at a reduced rate, when it is incubated in cell media
compared with phosphate buffer (data not shown). There-
fore, these results imply that the cell toxicity of fibrillar
RCMκ-CN is due to the presence of pre-formed fibrils.
Furthermore, the toxicity of native RCM κ-casein most
likely arises from fibrillar species that are present in
significant quantity due to the marked aggregation propen-
sity of RCM κ-casein which lacks a lag phase in its
aggregation profile (Thorn et al. 2005; Ecroyd et al. 2008;
Carver et al. 2010). Thus at 0.5 μM, the toxicity of RCMκ-
CN can be attributed to its fibrillar structure. Accordingly,
this concentration was used for subsequent experiments.
The prefibrillar oligomers and protofibrils of some
amyloid fibril-forming proteins, both disease related and
unrelated, have previously been shown to be more toxic
than, or as toxic as, mature fibrils (Bucciantini et al. 2002;
Du et al. 2003; Chimon et al. 2007; Simoneau et al. 2007).
By contrast, others have reported that mature fibrils are the
most cytotoxic species (Novitskaya et al. 2006). To address
the species responsible for the toxicity associated with
RCMκ-CN fibril formation, RCMκ-CN was pre-incubated
in phosphate buffer for specific time periods and aliquots
were taken at different stages of the fibril-forming process.
The TEM images (Fig. 2a–e) confirmed that native RCMκ-
CN (0 h) consists of primarily spherical, oligomeric
micelle-like species (Fig. 2a; Vreeman et al. 1981; Thorn
et al. 2005). Similar species were present after 1 h of
incubation (Fig. 2b); however, after 2 h of incubation, both
spherical oligomers and protofibril/short fibrillar structures
were observed (Fig. 2c). After 5 h of incubation, there was
a mixture of protofibrils and mature fibrils evident
(Fig. 2d), and after 20 h, more mature fibrils were observed
(Fig. 2e). RCMκ-CN incubated for 1 h and 2 h did not
significantly affect cell viability compared with the native
state of the protein (Fig. 2f); however, after 5 h of
incubation, there was a significant decrease in cell survival
compared with native RCMκ-CN. This level of toxicity
was maintained in the 20-h sample. These results indicate
that the toxicity of RCMκ-CN is dependent on the species
formed during the fibril-forming process.
The TEM images indicated that not all of the RCMκ-CN
had formed fibrils after 20 h (Fig. 2e), which raised the
possibility that the cell toxicity of the 20-h sample was due
to smaller oligomeric species present rather than the mature
fibrils and protofibrils. To determine whether the toxicity of
the 20-h sample was associated with the presence of small
RCMκ-CN oligomers, the 20-h sample was ultracentri-
fuged, and mature fibrils and protofibrils were separated
from the smaller oligomeric RCMκ-CN species. TEM
images indicated that following ultracentrifugation, the
pellet contained a mixture of mature fibrils and smaller
protofibrillar species (Fig. 3c) whereas the supernatant
contained predominately small β-sheet-rich oligomers with
a few short fibrils. The species present in the supernatant
were rich in β-sheet as indicated by their ability to bind
ThT (Fig. 3b). The species present in the pellet were
significantly more cytotoxic compared with native RCMκ-
CN and had the same level of toxicity as the 20-h sample
that had not been ultracentrifuged (Fig. 3a). In contrast, the
supernatant sample was no more cytotoxic than native
RCMκ-CN. Combined with the results presented in Fig. 2,
this suggests that mature RCMκ-CN fibrils and protofibrils
are more toxic than the smaller low molecular weight
prefibrillar oligomers.
Previous studies have shown that amyloid fibrils cause PC12
cell death via apoptosis (Troy et al. 2000, 2001; O'Donovan et
al. 2001; Tanaka et al. 2001; Onoue et al. 2002; Danzer et al.
2007). Therefore, in order to determine whether RCMκ-CN
fibrils also cause cell death via the apoptosis pathway, we
stained PC12 cells with the Hoechst DNA stain following
treatment with native and fibrillar RCMκ-CN. The images
show that more cells treated with fibrillar RCMκ-CN have
granular staining (Fig. 4), which indicates the condensed
chromatin typical of cells undergoing apoptosis. Thus, cells
treated with fibrillar RCMκ-CN exhibited granular staining
characteristic of late-stage apoptosis (top arrow in Fig. 4b) and
chromatin clumping typical of early stage apoptosis (bottom
two arrows in Fig. 4b).
Fig. 1 Concentration-dependent toxicity of native and fibrillar RCMκ-
CN. RCMκ-CN (500 μM) was dissolved in phosphate buffer (50 mM,
pH 7.4) and either frozen in its native form or incubated for 20 h at
37°C to induce fibril formation. Native (filled square) and fibrillar
(square) forms of RCMκ-CN (0–50 μM) were then added to the cell
culture media of the PC12 cells and the cells incubated for 48 h. Cell
survival was assessed using the MTT assay. Values are presented as
percentage of cell survival compared with control±SEM (n=6)
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Inhibition of fibril formation by RCMκ-CN leads
to a corresponding inhibition of the cytotoxicity associated
with this process
We have previously shown that αB-crystallin inhibits
RCMκ-CN fibril formation (Ecroyd et al. 2007; Rekas et
al. 2007). In this study, we extended this finding to
determine whether αB-crystallin also affected the cytotox-
icity associated with this process. αB-Crystallin inhibited
ThT fluorescence in a concentration-dependent manner
consistent with previous findings (Fig. 5a; Rekas et al.
2007), and this correlated with an inhibition of the toxicity
of RCMκ-CN to PC12 cells (Fig. 5b). These results
indicate that by inhibiting RCMκ-CN fibril formation,
αB-crystallin protects against fibril-induced cell toxicity.
In addition, both αS- and β-casein, the natural binding
partners of κ-casein in milk micelles, completely inhibited
RCMκ-CN fibril formation at a 1.6:1.0 and 0.8:1.0 mol/mol
ratio, consistent with our previous findings (Fig. 6a; Thorn
et al. 2005). At these concentrations, αS- and β-casein also
significantly inhibited the cytotoxicity associated with fibril
formation by RCMκ-CN (Fig. 6b). At a 0.4:1.0 mol/mol
ratio, αS- and β-casein inhibited ThT fluorescence by 90%
and 80%, respectively. However, there was still significant
Fig. 2 Time-dependent toxicity
of RCMκ-CN. a–e Electron
micrographs of RCMκ-CN
(125 μM) after a 0 h, b 1 h, c
2 h, d 5 h, and e 20 h incubation
at 37°C, showing fibril forma-
tion. Scale bar, 200 nm. f
RCMκ-CN (125 μM) was dis-
solved in phosphate buffer
(50 mM, pH 7.4) and incubated
at 37°C to induce fibril forma-
tion. Samples were taken over 0
to 20 h incubation and added to
the cell culture media of the
PC12 cells (0.5 μM final con-
centration). The cells were in-
cubated for 48 h followed by an
MTT assay to assess cell sur-
vival. Values are presented as
percentage of cell survival com-
pared with control±SEM. **p<
0.01 compared with 0 h incuba-
tion (n=4, one-way ANOVA,
Dunnett’s test)
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RCMκ-CN toxicity present at this ratio, implying that there
were sufficient species present under these conditions to
cause cytotoxicity. Thus, while αS- and β-casein inhibit
fibril formation at low concentrations, complete inhibition
is required before their beneficial effects against fibril-
associated cell toxicity are observed.
Effect of αB-crystallin on the cytotoxicity associated
with fibril formation by Aβ1–40
We examined whether the ability of αB-crystallin to
prevent the toxicity associated with fibril formation extends
to a disease-relevant amyloidogenic species, namely the
Fig. 4 Hoechst staining of PC12 cells treated with native and fibrillar
RCMκ-CN. RCMκ-CN (500 μM) was dissolved in phosphate buffer
(50 mM, pH 7.4) and either frozen in its native form or incubated for
20 h at 37°C to induce fibril formation. a Native or b fibrillar forms of
RCMκ-CN (0.5 μM) were then added to the cell culture media of the
PC12 cells, the cells incubated for 48 h, and then stained with Hoechst
33258. Arrows indicate condensed or fragmented nuclei
Fig. 3 Analysis of RCMκ-CN following ultracentrifugation. a
RCMκ-CN (125 μM) was dissolved in phosphate buffer (50 mM,
pH 7.4) and incubated for 20 h at 37°C to induce fibril formation. The
sample was then ultracentrifuged at 90,000 rpm, supernatant removed,
and the pellet resuspended in an equal volume of phosphate buffer. An
equal aliquot of the supernatant and pellet was added to the PC12
cells, and the cells were incubated for 48 h followed by an MTT assay
to assess cell survival. Values are presented as percentage of cell
survival compared with control±SEM. *p<0.05 compared with 0 h
incubation. Dagger sign, p<0.05 compared with 20 h incubation (n=
6, one-way ANOVA, Bonferroni’s test). b ThT fluorescence of
pelleted RCMκ-CN and resulting supernatant. c, d Electron micro-
graphs of c pelleted RCMκ-CN and d resulting supernatant. Scale bar,
200 nm
αB-Crystallin inhibits amyloid fibril cell toxicity 1019
Aβ1–40 peptide. Previous studies in this area have produced
conflicting results (Stege et al. 1999; Wilhelmus et al.
2006a, b). In particular, it has been proposed that αB-
crystallin stabilizes a toxic form of Aβ1–40 during its fibril-
forming process (Stege et al. 1999). However, in these
studies, native Aβ and αB-crystallin were applied directly
to the cell culture media and the inhibition of fibril
formation by αB-crystallin in this media was not estab-
lished. In the study herein, we sought to definitively
establish the effect of αB-crystallin on the cytotoxicity
associated with fibril formation by Aβ. To this end, we pre-
incubated Aβ1–40 in the absence or presence of αB-
crystallin before exposure to PC12 cells. Aβ1–40 formed
mature fibrils over 48–72 h as indicated by TEM and ThT
fluorescence (Fig. 7a–d). At 0 h, there was some oligomeric
Aβ1–40 present (Fig. 7a). Larger oligomeric species were
observed after 24 h (Fig. 7b), and mature fibrils were
observed after 48 and 72 h (Fig. 7c, d). When monitored by
in situ ThT fluorescence, the formation of Aβ1–40 fibrils
included a long lag phase of approximately 20 h followed
by a growth phase, which reached a plateau at approxi-
mately 72 h (Fig. 8a). In a similar manner to RCMκ-CN,
the toxicity of Aβ1–40 was time-dependent, with Aβ1–40
fibrils formed after 48 and 72 h producing a significant
decrease in cell survival compared with native Aβ1–40,
whereas smaller aggregates, formed after 24 h, decreased
cell survival but this was not found to be significant
(Fig. 7e). αB-Crystallin completely inhibited Aβ1–40 fibril
formation at a 1:100 mol/mol ratio as indicated by the
inhibition of ThT fluorescence and the absence of fibrils
when viewed by TEM (Fig. 8a, b). Significantly, when the
samples of Aβ1–40 incubated with αB-crystallin were added
to PC12 cells, there was a significant decrease in the cell
toxicity of Aβ1–40 (Fig. 8c). Together, these results show
that inhibition of Aβ1–40 amyloid fibril formation by αB-
crystallin results in an abolishment of the cell toxicity
associated with this process and therefore definitively
establishes that the species formed during the interaction
between these two proteins is not cytotoxic to cells.
Discussion
We (Thorn et al. 2005, 2009; Ecroyd et al. 2007, 2008) and
others (Farrell et al. 2003) have shown previously that
RCMκ-CN rapidly forms amyloid fibrils under conditions
of physiological temperature and pH via a nucleation-
dependent mechanism. For the present study, we have
extended these findings to show that fibrils formed by this
protein are toxic to PC12 cells (Fig. 1). Our results are
consistent with the hypothesis that the toxicity of amyloid
fibril-forming proteins is inherent in the mechanism of fibril
formation and/or the amyloid fibril structure and that there
is a common mechanism of toxicity for amyloid-forming
proteins (Bucciantini et al. 2002). Furthermore, as RCMκ-
CN forms fibrils under physiological conditions in a
relatively short timeframe and without the need for
denaturants, it is a good model to study the fibril-forming
process and its associated cell toxicity.
Previous cell culture studies have shown that prefibrillar
oligomers, protofibrils, and mature fibrils of fibril-forming
proteins are toxic, although the relative level of toxicity
between these species appears to be dependent on the
specific fibril-forming protein. For instance, prion protein
oligomers were highly toxic to cortical neurons whereas
mature prion protein fibrils demonstrated very little toxicity
(Simoneau et al. 2007). However, in a similar study in
SH-SY5Y cells and hippocampal neurons, mature prion
protein fibrils were as toxic as smaller oligomeric species
(Novitskaya et al. 2006). For Aβ, β-sheet-rich oligomers,
protofibrils, and mature fibrils were toxic (Hartley et al.
1999; Hoshi et al. 2003; Chimon et al. 2007), and in a study
Fig. 5 Effect of αB-crystallin on RCMκ-CN fibril formation and
toxicity. a RCMκ-CN (50 μM) was dissolved in phosphate buffer
(50 mM, pH 7.4) and incubated for 20 h at 37°C in the absence (filled
circle) or presence of αB-crystallin at 5 μM (square), 25 μM (filled
triangle), 50 μM (diamond), and 100 μM (filled diamond); and fibril
formation was measured by in situ ThT fluorescence. b Samples from
the ThT assay were added to the PC12 cells so that the final
concentration of RCMκ-CN was 0.5 μM. The cells were incubated for
48 h followed by an MTT assay to assess cell survival. Values are
presented as percentage of cell survival compared with control±SEM.
**p<0.01, ***p<0.001 compared with 20 h RCMκ-CN (n=3, one-
way ANOVA, Dunnett’s test)
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on fibril formation and cell toxicity of non-disease-related
proteins, prefibrillar and protofibrillar aggregates were
cytotoxic whereas the mature fibrils exhibited no significant
toxicity (Bucciantini et al. 2002). Our research indicates
that RCMκ-CN fibrils and protofibrils are more toxic than
small molecular weight prefibrillar oligomers and the native
state of the protein. Thus, after 5 h of incubation, RCMκ-
CN formed a mixture of protofibrils and mature fibrils that
was significantly more toxic to cells compared with the
smaller prefibrillar oligomers formed following 2 h of
incubation (Fig. 2). Similar results were observed for Aβ1–40,
where the species formed after 48 and 72 h of incubation
were significantly cytotoxic compared with native Aβ1–40,
whereas the species present following 24 h of incubation was
not (Fig. 7). It is worth noting that while our data suggest
that the mature fibrils formed by both RCMκ-CN and Aβ1–40
are toxic to neuronal cells, we observed similar levels of
cytotoxicity at time points where the ThT fluorescence was
not maximal (i.e., 5 h for RCMκ-CN and 48 h for Aβ1–40).
Thus, from these data, we conclude that protofibrillar
species, on the pathway to forming mature fibrils and
therefore more abundant in these earlier time point samples,
appear to be as toxic to neuronal cells as the mature fibrils.
To investigate this further with regard to RCMκ-CN, we
ultracentrifuged the sample that had been incubated for 20 h
in order to separate the low molecular weight species in the
supernatant (native state and β-sheet-rich prefibrillar
oligomers) from the high molecular weight species in the
pellet (protofibrils and mature fibrils). We found that the
species present in the supernatant did not significantly
affect cell survival, having the same level of toxicity as the
native state of the protein. In contrast, the high molecular
weight fibrils and protofibrils collected in the pellet had the
same level of toxicity as the non-centrifuged sample
(Fig. 3). In previous studies showing the toxicity of Aβ
oligomers, β-sheet-rich oligomers were isolated and con-
centrated from mature Aβ fibrils using size-exclusion
chromatography or centrifugation through molecular weight
cutoff membranes or density gradients, which led to the
isolation of β-sheet-rich oligomers that were highly toxic to
cells (Hartley et al. 1999; Hoshi et al. 2003; Chimon et al.
2007). Interestingly, it has been suggested that larger
oligomers with a protofibrillar or spherical shape are more
toxic than smaller oligomers (Ward et al. 2000; Hoshi et al.
2003; Chimon et al. 2007). Chimon et al. (2007) found that
mature fibrils and β-sheet-rich oligomers with a molecular
mass greater than 50 kDa were far more toxic to PC12 cells
than oligomers smaller than 50 kDa. Similarly, Ward et al.
(2000), using density–gradient centrifugation, showed that
fractions containing protofibrils and mature fibrils were
more toxic than those containing smaller oligomers. From
our results using Aβ1–40, we conclude that the cytotoxic
Aβ species are formed at later time points during the fibril-
forming process (as the toxicity of the sample did not
become significant until 48 h of incubation, see Fig. 7) and
then, either the concentration of this cytotoxic Aβ species
Fig. 6 Effect of αS-casein and
β-casein on RCMκ-CN fibril
formation and toxicity. a
RCMκ-CN (50 μM) was dis-
solved in phosphate buffer
(50 mM, pH 7.4) and incubated
for 20 h at 37°C in the absence
(filled circle) or presence of
either αS-casein (i) or β-casein
(ii) at 20 μM (square), 40 μM
(filled triangle), and 80 μM
(diamond); and fibril formation
was measured by in situ ThT
fluorescence. b Samples from
the ThT assay were added to the
PC12 cells so that the final
concentration of RCMκ-CN was
0.5 μM. The cells were incu-
bated for 48 h followed by an
MTT assay to assess cell sur-
vival. Values are presented as
percentage of cell survival com-
pared with control±SEM.
***p<0.001 compared with
20 h RCMκ-CN (n=3, one-way
ANOVA, Dunnett’s test)
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is maintained or more mature species, formed from it, have
similar levels of toxicity. Similar techniques to those used
in the studies on the cytotoxic Aβ species could be
employed to determine more precisely the relative toxicities
of species formed during fibril formation by RCMκ-CN. Of
note, with studies that apply particular forms of protein
along its fibril-forming pathway, is that fibril formation still
occurs in the incubation media used for the toxicity studies
and, since the process of fibril formation is a dynamic one,
changes in the relative amounts of each species during the
incubation period need to be considered in interpretation of
these data.
Previous studies in PC12 cells and other cell lines have
shown that Aβ, α-synuclein, and the prion protein enhance
cell toxicity through apoptotic mechanisms (Troy et al.
2000, 2001; O'Donovan et al. 2001; Tanaka et al. 2001;
Onoue et al. 2002; Danzer et al. 2007). Furthermore,
enhanced activity of apoptotic mediators such as caspases
is observed in the brains of patients with AD and PD
(Mattson 2006), which suggests that fibril-forming proteins
cause cell death, in part, via apoptosis. Similarly, Hoechst
staining showed that fibrillar RCMκ-CN enhanced chro-
matin condensation and fragmentation (Fig. 4), which
indicates that RCMκ-CN causes PC12 cell death via
apoptosis.
Previous research has shown that fibrillar aggregates of
non-disease-related proteins are toxic, which suggests that
amyloid fibrils share a common mechanism of toxicity
(Bucciantini et al. 2002). Our study herein demonstrates
that molecular chaperones are important in preventing
Fig. 7 Time-dependent toxicity
of Aβ1–40. a–d Electron micro-
graphs of Aβ1–40 fibril forma-
tion after a 0 h, b 24 h, c 48 h,
and d 72 h. Scale bar, 1 μm. e
Aβ1–40 (10 μM) was dissolved
in phosphate buffer (50 mM,
pH 7.4) and incubated at 37°C
to induce fibril formation.
Samples were taken over 0 to
72 h incubation and added to the
cell culture media of the PC12
cells (0.5 μM final concentra-
tion). The cells were incubated
for 48 h followed by an MTT
assay to assess cell survival.
Values are presented as percent-
age of cell survival compared
with control±SEM. *p<0.05,
**p<0.01 compared with 0 h
incubation (n=4, one-way
ANOVA, Dunnett’s test)
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generic aspects of fibril formation and the toxicity
associated with this process (Ecroyd and Carver 2009).
Thus, αB-crystallin inhibited fibril formation by RCMκ-
CN and Aβ, and this correlated with a reduction in the cell
toxicity of these amyloid fibrils. In vivo, the upregulation of
sHsps, which occurs in a variety of protein misfolding
diseases, and their co-localization to amyloid deposits
(Lowe et al. 1992; Shinohara et al. 1993; Renkawek et al.
1994; McLean et al. 2002; Pountney et al. 2005; Wilhelmus
et al. 2006a, b), may represent an important protective
effect to mitigate fibril formation and halt the progression
of these diseases. Indeed, the recent observation for an
intracellular phase of Aβ aggregation prior to extracellular
fibril release (Friedrich et al. 2010) provides a plausible
explanation for the collocation of αB-crystallin with Aβ in
the extracellular plaques associated with AD.
One explanation for the contrasting results in the
literature addressing the effect of αB-crystallin on the cell
toxicity of Aβ (Stege et al. 1999; Wilhelmus et al. 2006a, b)
is the methodology used to test the toxicity of Aβ. For both
these studies, the native proteins were directly added to
the cell media. As a result, it is unclear whether the effect
of αB-crystallin on cell toxicity is directly related to its
interaction with the fibril-forming protein or other
components in the cell media. In previous studies showing
the effect of Hsp20, another member of the sHsp family,
on the toxicity of Aβ1–40, the two proteins were pre-
incubated before addition to the cell culture media (Lee et
al. 2005, 2006) in a similar manner to that undertaken
herein. Pre-incubation has the advantage that the effect of
αB-crystallin on the fibril-forming protein can be readily
monitored by ThT and TEM and the species being added
to the cell media (i.e., mature fibril, prefibrillar oligomer,
amorphous aggregate, etc.) is well characterized. Lee et al.
(2005, 2006) found that Hsp20 inhibited fibril formation
by Aβ1–40 and that the resultant Aβ1–40 species were not
toxic to PC12 and SH-SY5Y cells. However, other sHsps,
Hsp17.7 and Hsp27, did not inhibit the toxicity of Aβ1–40
despite preventing its fibril formation, and Aβ1–40 species
had a different morphology in the presence of Hsp17.7 and
Hsp27 compared with Hsp20 (Lee et al. 2006) implying
that Hsp17.7 and Hsp27 may not prevent the formation of
smaller, toxic Aβ oligomers.
Consistent with our previous work (Ecroyd et al. 2007),
αB-crystallin was not as efficacious in preventing RCMκ-
CN fibril formation compared with other fibril-forming
proteins. Thus, αB-crystallin caused a 67% inhibition of
RCMκ-CN ThT fluorescence at a 2.0:1.0 mol/mol ratio. In
comparison, αB-crystallin completely inhibited Aβ fibril
formation at 0.01:1.0 mol/mol ratio, a potency similar to
that reported by Raman et al. (2005). The marked
difference in potency with these two target proteins may
be due to the different kinetics of RCMκ-CN fibril
formation compared with other amyloid proteins. Amyloid
fibril aggregation occurs via a nucleation-dependent pro-
cess where the formation of nuclei is the rate-limiting step.
We have recently shown that RCMκ-CN aggregates via
such a mechanism but the formation of nuclei is not the
Fig. 8 Effect of αB-crystallin
on Aβ1–40 fibril formation and
toxicity. a Aβ1–40 (10 μM) was
dissolved in phosphate buffer
(50 mM, pH 7.4) and incubated
for 72 h at 37°C in the absence
(filled circle) or presence of αB-
crystallin at 0.1 μM (square),
1 μM (filled triangle), and
10 μM (diamond); and fibril
formation was measured by in
situ ThT fluorescence. b
Electron micrographs of Aβ1–40
(10 μM) after 72 h in the
presence of αB-crystallin at
0.1 μM (i) and 10 μM (ii). Scale
bar, 1 μm. c Samples from the
ThT assay were added to the
PC12 cells so that the final
concentration of Aβ1–40 was
0.5 μM. The cells were incu-
bated for 48 h followed by an
MTT assay to assess cell
survival. Values are presented as
percentage of cell survival
compared with control±SEM.
***p<0.001 compared with
72 h Aβ1–40 (n=3, one-way
ANOVA, Dunnett’s test)
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rate-limiting step for fibril formation, as indicated by the
lack of effect of seeding and absence of a protein
concentration-dependent lag phase (Ecroyd et al. 2008).
Once formed, the amyloidogenic precursor to RCMκ-CN
fibril formation does not persist for long in solution and
therefore, the ability of αB-crystallin to interact with and
stabilize it is reduced. In contrast, fibril formation by
Aβ1–40 has a long lag phase (approximately 20 h) providing
significant opportunity for an interaction between αB-
crystallin and partially folded intermediate states of Aβ1–40.
αB-Crystallin prefers to interact with slowly aggregating
target proteins, whether they are doing so amorphously
(Lindner et al. 2001) or in a fibrillar manner (Rekas et al.
2007). Thus, in diseases associated with fibril formation,
conditions which increase the rate of fibril formation (e.g.,
mutations, stress, seeded fibrils) may exacerbate the disease
due to a corresponding decrease in the effectiveness of the
chaperone ability of sHsps to inhibit fibril formation.
The chaperone activity of αS- and β-casein in preventing
fibril formation by κ-casein (Thorn et al. 2005) also led to an
inhibition of the RCMκ-CN-induced cell toxicity at mol/mol
ratios of 0.8:1.0 and 1.6:1.0 (which are the approximate
ratios found in milk for these proteins). Thus in vivo, the
casein micelle in milk is important in stabilizing κ-casein to
prevent its fibril formation and its potential toxic effects. This
is of particular relevance to corpora amylacea, a disease
characterized by amyloid-like deposits in bovine, rat, and
canine mammary tissue (Reid 1972; Beems et al. 1978;
Taniyama et al. 2000; Gruys 2004; Thorn et al. 2009).
Bundles of fibrils have also been reported in the cytoplasm
of cells that surround these calcified deposits (Nickerson
1987). Formation of fibrils associated with corpora amylacea
is likely to be toxic to the surrounding cells which would be
prevented by micelle formation of the casein proteins.
In summary, we have shown that RCMκ-CN is toxic to
PC12 cells and that its toxicity can be attenuated by
inhibiting its fibril formation utilizing molecular chaper-
ones. RCMκ-CN is therefore a useful model for investigat-
ing the generic mechanism of fibril formation, the
cytotoxicity associated with this process, as well as
inhibitors of fibril formation that may be potential thera-
peutics for the treatment of fibril-associated diseases. We
have used RCMκ-CN and Aβ as model fibril-forming
proteins to directly demonstrate that the inhibition of fibril
formation by the sHsp, αB-crystallin, leads to a decrease in
cell toxicity. These results highlight the important role of
sHsps in inhibiting the cell toxicity associated with fibril
formation in protein misfolding diseases.
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